{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:20:53Z","timestamp":1784092853114,"version":"3.55.0"},"reference-count":30,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Blekinge County Council\u2019s Research and Development Foundation"},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Chron Respir Dis"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Use of long-term oxygen therapy (LTOT) for more than 15\u00a0h per day does not reduce mortality or hospitalizations, but may increase the risk of adverse events. We evaluated the relationship between daily oxygen use duration and adverse events, symptoms, and health status in patients on LTOT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This was a cross-sectional survey study of a random sample (\n                      <jats:italic>N<\/jats:italic>\n                      = 650) of adults with ongoing LTOT in Sweden. Oxygen use (h\/day) was reported, and associations were analyzed with adverse events, symptom severities (revised Edmonton Symptom Assessment System), sleep duration and quality, and health status (COPD assessment test [CAT]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, surveys from 204 patients were analyzed; 60% female, mean age 75.3 (SD 8.7) years. Swedevox baseline characteristics were similar between sampled respondents and non-respondents. Patients reporting 24\u00a0h of daily oxygen use (53.4%) also reported a higher number of total adverse events, higher ratings of dyspnea, depression and anxiety, and worse health status, compared to those reporting fewer hours of oxygen use. A longer daily duration of oxygen use also associated with a higher number of experienced adverse events, higher ratings of dyspnea and anxiety, and worse rated health status in crude and adjusted linear regression models. No associations were seen between oxygen use duration and sleep quality or duration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>More adverse events, a higher severity of some symptoms, and worse health status are seen among patients with a longer daily duration of oxygen use. Further research is needed to establish evidence of causality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/14799731251366962","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T13:24:42Z","timestamp":1754659482000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Longer daily oxygen use associates with more adverse events, symptoms, and worse health status in long-term oxygen therapy"],"prefix":"10.1177","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5199-3570","authenticated-orcid":false,"given":"Filip","family":"Bj\u00f6rklund","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Department of Clinical Sciences Lund, Respiratory Medicine, Allergology, and Palliative Medicine, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Ekstr\u00f6m","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Clinical Sciences Lund, Respiratory Medicine, Allergology, and Palliative Medicine, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-93-3-391"},{"issue":"8222","key":"e_1_3_5_3_2","first-page":"681","article-title":"Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the medical research council working party","volume":"1","year":"1981","unstructured":"Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the medical research council working party. Lancet 1981; 1(8222):681\u2013686.","journal-title":"Lancet"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2023-221063"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-206865"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202009-3608ST"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/140.3_Pt_2.S95"},{"key":"e_1_3_5_8_2","doi-asserted-by":"crossref","unstructured":"Ekstr\u00f6m M Andersson A Papadopoulos S et al. Long-term oxygen therapy for 24 or 15 hours per day in severe hypoxemia. N Engl J Med 2024; 391: 977\u2013988.","DOI":"10.1056\/NEJMoa2402638"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S295885"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2015.01.005"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S140264"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2023.107306"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2012.02217.x"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0173"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2003.10.008"},{"issue":"1","key":"e_1_3_5_16_2","first-page":"7","article-title":"Psychological status of COPD patients before and after one year of long-term oxygen therapy","volume":"51","author":"Borak J","year":"1996","unstructured":"Borak J, Sliwi\u0144ski P, Tobiasz M, et al. Psychological status of COPD patients before and after one year of long-term oxygen therapy. Monaldi Arch Chest Dis 1996; 51(1): 7\u201311.","journal-title":"Monaldi Arch Chest Dis"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1177\/1479972318767724"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/325362"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2005.09.018"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2019.02.004"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202110-1174OC"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269216318805621"},{"key":"e_1_3_5_23_2","volume-title":"\u00c5rsrapport fr\u00e5n andningssviktsregistret","author":"Swedish National Register for Respiratory Failure (Swedevox)","year":"2023","unstructured":"Swedish National Register for Respiratory Failure (Swedevox). \u00c5rsrapport fr\u00e5n andningssviktsregistret. 2023; Available from. https:\/\/www.ucr.uu.se\/swedevox\/ [Accessed February 2025]."},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00340-2020"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2016.10.370"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2017.1366050"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.3109\/15412555.2011.630248"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2012.02131.x"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S159666"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(98)90035-X"}],"container-title":["Chronic Respiratory Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/14799731251366962","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/14799731251366962","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/14799731251366962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:48:24Z","timestamp":1777394904000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/14799731251366962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":30,"alternative-id":["10.1177\/14799731251366962"],"URL":"https:\/\/doi.org\/10.1177\/14799731251366962","relation":{},"ISSN":["1479-9731","1479-9731"],"issn-type":[{"value":"1479-9731","type":"print"},{"value":"1479-9731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]},"article-number":"14799731251366962"}}